2025 Dickson Prize in Medicine Goes to Professor Sir Cato T. Laurencin of UConn
The Dickson Prize in Medicine is awarded annually to a leading American investigator engaged in innovative and paradigm-shifting biomedical research. It is an esteemed annual award presented by the University of Pittsburgh. Many recipients of the Dickson Prize have gone on to receive the Nobel Prize. Dr. Cato T. Laurencin is the founder and pioneer of the field of regenerative engineering.
His lecture, “Regenerative Engineering: Breakthroughs in Medicine,” will be given at 2:30 p.m. on July 11 at the University of Pittsburgh, Alan Magee Scaife Hall West Wing Auditorium. It will be followed by a panel discussion and reception at 5 p.m.
Laurencin is a University Professor (one of two at UConn) and professor of Chemical and Biomolecular Engineering, professor of Materials Science and Engineering, and professor of Biomedical Engineering. He is the chief executive officer of The Cato T. Laurencin Institute for Regenerative Engineering, a cross-university Institute created in his honor. At UConn School of Medicine he is the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery.
He is the leading international figure in polymer science and engineering as applied to musculoskeletal biology. Renowned for his work in areas including biomaterials science and materials chemistry, his broad background and insight have allowed him to move research from fundamental science to applied research, to research translation and clinical treatment.
Laurencin earned his B.S.E. in Chemical Engineering from Princeton University, his M.D., Magna Cum Laude, from the Harvard Medical School, and earned his Ph.D. in Biochemical Engineering/Biotechnology from the Massachusetts Institute of Technology. He completed an orthopaedic surgery residency at Harvard, where he was named Chief Resident at the Beth Israel Hospital, Harvard Medical School. A specialist in shoulder surgery and sports medicine, he completed fellowship training at the Hospital for Special Surgery in New York.
Laurencin is a fellow of the American Academy of Orthopaedic Surgeons, a fellow of the American Orthopaedic Association, a fellow of the American College of Surgeons, an elected member of the American Surgical Association and an elected member of the Association of Bone and Joint Surgeons. In orthopaedic surgery, he received the Nicolas Andry Lifetime Achievement Award, the highest honor of the Association of Bone and Joint Surgeons, the Kappa Delta Award, the highest research honor from the American Academy of Orthopaedic Surgeons, the Marshall R. Urist Award, honoring an investigator who has a sustained ongoing body of research in tissue regeneration as it relates to the musculoskeletal system, from the Orthopaedic Research Society, and the American Orthopaedic Association’s (AOA) Distinguished Contributions to Orthopaedics Award with induction into the AOA Awards Hall of Fame. He is the first individual to receive these four awards.
He is the first surgeon in history elected to the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors.
In 2025, he received Knighthood under the auspices of King Charles III of England by the Governor General of St. Lucia.
Latest UConn Today
- Milestone for Favarh’s Project SEARCH at UConn HealthClass of 2025 is 10th cohort; All 5 graduates hired to independent employment
- UConn Health Named One of Newsweek’s Best Maternity HospitalsUConn Health has once again earned national recognition, this time as one of Newsweek’s Best Maternity Hospitals. The honor celebrates the dedication of our providers, nurses, and staff who go above and beyond to ensure every patient receives safe, expert, and compassionate care. For families like Rebecca’s, that commitment isn’t just recognized,it’s deeply personal.
- How to Partner With Industry (by Really Trying)Successful UConn researchers offer Insight on fruitful collaboration with private industry
- Fighting Poultry Disease with mRNA: UConn Researchers Pioneer Nanoparticle ApproachUConn researchers have demonstrated that a novel protein-based nanoparticle can make mRNA vaccines more effective to tackle a troublesome pathogen in chickens
- Message to the Community Regarding the State BudgetPresident Maric discusses the impact on UConn and UConn Health
- Empowering Equity in the Emergency DepartmentGrassroot diversity, equity, and inclusion efforts are improving care and experience for UConn Health’s most vulnerable patients.